SNY Competition Analysis

Sanofi Peer Comparison

Metric	Value	Ranking
Market Cap	$124.1 Billion	7/10	JNJ $349.0B	ABBV $302.8B	MRK $253.2B	AZN $203.7B	NVS $193.8B	AMGN $144.6B	SNY $124.1B	GILD $115.1B	BMY $113.4B	GSK $75.4B
Gross Margin	68%	8/10	MRK 80%	AZN 77%	BMY 75%	GSK 74%	NVS 74%	ABBV 71%	JNJ 70%	SNY 68%	AMGN 61%	GILD -100%
Profit Margin	11%	7/10	AMGN 33%	NVS 25%	MRK 19%	GILD 17%	GSK 15%	JNJ 12%	SNY 11%	ABBV 11%	AZN 11%	BMY 10%
EBITDA margin	26%	7/10	ABBV 49%	NVS 44%	BMY 38%	GSK 33%	JNJ 32%	AZN 30%	SNY 26%	MRK 25%	AMGN 24%	GILD 12%
Quarterly Revenue	$23.3 Billion	1/10	SNY $23.3B	JNJ $22.5B	MRK $16.7B	ABBV $14.5B	AZN $13.6B	NVS $12.8B	BMY $11.9B	GSK $10.1B	AMGN $8.5B	GILD $7.6B
Quarterly Earnings	$2.5 Billion	5/10	NVS $3.2B	MRK $3.2B	AMGN $2.8B	JNJ $2.7B	SNY $2.5B	ABBV $1.6B	GSK $1.5B	AZN $1.4B	GILD $1.3B	BMY $1.2B
Quarterly Free Cash Flow	-$553.8 Billion	10/10	MRK $8.5B	NVS $6.0B	BMY $5.3B	ABBV $5.2B	GILD $4.5B	AMGN $3.3B	AZN $2.0B	GSK $564.1M	JNJ -$0	SNY -$553.8M
Trailing 4 Quarters Revenue	$74.6 Billion	2/10	JNJ $87.7B	SNY $74.6B	MRK $63.2B	ABBV $55.5B	AZN $51.2B	NVS $48.9B	BMY $47.4B	GSK $40.3B	AMGN $32.5B	GILD $28.3B
Trailing 4 Quarters Earnings	$8.7 Billion	4/10	SNY $23.3B	JNJ $22.5B	MRK $16.7B	ABBV $14.5B	AZN $13.6B	NVS $12.8B	BMY $11.9B	GSK $10.1B	AMGN $8.5B	GILD $7.6B
Quarterly Earnings Growth	57%	3/10	NVS 81%	AMGN 64%	SNY 57%	AZN 4%	ABBV -12%	GSK -28%	MRK -33%	BMY -37%	GILD -43%	JNJ -90%
Annual Earnings Growth	6%	3/10	MRK 192%	NVS 102%	SNY 6%	AZN -5%	AMGN -28%	GSK -34%	ABBV -35%	JNJ -65%	GILD -98%	BMY -189%
Quarterly Revenue Growth	99%	1/10	SNY 99%	AMGN 23%	AZN 18%	GSK 10%	BMY 8%	GILD 7%	NVS 6%	JNJ 5%	ABBV 4%	MRK 4%
Annual Revenue Growth	57%	1/10	SNY 57%	AMGN 17%	GSK 12%	AZN 12%	BMY 6%	GILD 5%	MRK 3%	ABBV 0%	NVS -9%	JNJ -10%
Cash On Hand	$7.5 Billion	5/10	MRK $14.6B	NVS $13.6B	AMGN $9.0B	BMY $7.9B	SNY $7.5B	ABBV $7.3B	AZN $4.8B	GSK $3.8B	GILD -$0	JNJ -$0
Short Term Debt	$10.5 Billion	2/10	ABBV $12.6B	SNY $10.5B	NVS $6.8B	GSK $4.3B	AMGN $3.5B	MRK $3.1B	AZN $1.6B	BMY $1.1B	GILD -$0	JNJ -$0
Long Term Debt	$13.7 Billion	8/10	ABBV $58.5B	AMGN $56.9B	BMY $48.7B	MRK $35.0B	AZN $30.0B	NVS $23.8B	GSK $17.4B	SNY $13.7B	GILD $0	JNJ $0
PE	14.35	8/10	GILD 913.73	ABBV 59.05	AMGN 34.18	AZN 31.36	JNJ 23.77	MRK 20.84	GSK 14.58	SNY 14.35	NVS 11.01	BMY -1.00
PS	1.51	9/10	ABBV 5.45	AMGN 4.45	GILD 4.07	MRK 4.01	JNJ 3.98	AZN 3.98	NVS 3.96	BMY 2.39	SNY 1.51	GSK 1.46
PB	1.55	10/10	ABBV 49.88	AMGN 19.21	BMY 6.59	MRK 5.68	AZN 4.99	JNJ 4.88	NVS 4.46	GSK 4.27	GILD 2.69	SNY 1.55
PC	16.62	5/10	AZN 42.46	ABBV 41.73	GSK 19.86	MRK 17.35	SNY 16.62	AMGN 16.04	BMY 14.37	NVS 14.24	GILD -1.00	JNJ -1.00
Liabilities to Equity	0.78	8/10	ABBV 22.77	AMGN 11.07	BMY 4.46	GSK 3.08	MRK 1.64	AZN 1.57	NVS 1.39	SNY 0.78	GILD 0.00	JNJ -1.00
ROA	0.07	4/10	NVS 17%	MRK 10%	GSK 9%	SNY 7%	AZN 6%	AMGN 5%	ABBV 4%	GILD 0%	BMY -8%	JNJ -100%
ROE	0.12	8/10	ABBV 85%	AMGN 56%	NVS 41%	GSK 36%	MRK 27%	JNJ 21%	AZN 16%	SNY 12%	BMY -42%	GILD -100%
Current Ratio	2.29	2/10	GILD 4.65	SNY 2.29	NVS 1.72	AZN 1.64	MRK 1.61	GSK 1.31	BMY 1.22	AMGN 1.09	ABBV 1.04	JNJ 0.00
Quick Ratio	0.12	4/10	GILD 913.73	ABBV 59.05	AMGN 34.18	AZN 31.36	JNJ 23.77	MRK 20.84	GSK 14.58	SNY 14.35	NVS 11.01	BMY -1.00
Long Term Debt to Equity	0.17	8/10	ABBV} 9.70	AMGN} 7.55	BMY} 2.84	GSK} 0.94	MRK} 0.79	AZN} 0.74	NVS} 0.55	SNY} 0.17	JNJ} 0.00	GILD} -1.00
Debt to Equity	0.33	8/10	ABBV 11.78	AMGN 8.02	BMY 2.90	GSK 1.18	MRK 0.86	AZN 0.78	NVS 0.71	SNY 0.33	JNJ 0.00	GILD -1.00
Burn Rate	16.54	3/10	AZN 29.40	AMGN 27.29	SNY 16.54	BMY 7.85	ABBV 1.85	GILD 0.00	JNJ 0.00	MRK -15.04	GSK -24.84	NVS -25.40
Cash to Cap	0.06	3/10	BMY 0.07	NVS 0.07	SNY 0.06	MRK 0.06	AMGN 0.06	GSK 0.05	ABBV 0.02	AZN 0.02	GILD 0.00	JNJ 0.00
CCR	-0.22	10/10	BMY 4.35	GILD 3.63	ABBV 3.33	MRK 2.69	NVS 1.87	AZN 1.42	AMGN 1.17	GSK 0.38	JNJ 0.00	SNY -0.22
EV to EBITDA	28.23	10/10	GILD} 129.65	AMGN} 95.73	MRK} 67.66	AZN} 56.18	ABBV} 52.05	JNJ} 49.16	GSK} 42.17	NVS} 37.52	BMY} 33.91	SNY} 28.23
EV to Revenue	2.06	10/10	ABBV 6.60	AMGN 6.03	AZN 4.50	MRK 4.38	NVS 4.31	GILD 4.07	JNJ 3.98	BMY 3.27	GSK 2.74	SNY 2.06

Sanofi Peer Comparison

Cookies